[Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behavior and lipid composition of the serum].

Die Medizinische Welt 04/1979; 30(11):411-6.
Source: PubMed
1 Read
  • [Show abstract] [Hide abstract]
    ABSTRACT: Unter den vielen Pflanzenlecithinen, die bei der Verarbeitung von Ölsaaten anfallen, hat bisher nur das Sojalecithin kommerzielle Bedeutung erlangt. Es kommt in vielen Varianten in den Handel und wird als Additiv in technischen Produkten, Lebens- und Futtermitteln, pharmazeutischen Präparaten und anderen Erzeugnissen verwendet. Einer breiten Öffentlichkeit ist es-allerdings nicht unumstritten–als Stärkungs- und Heilmittel sowie als Geriatricum bekannt geworden. In diesem Bericht werden die wissenschaftlichen Grundlagen behandelt, die den bisherigen Anwendungsgebieten zugrundeliegen, und die Erfolgsaussichten weitere Entwicklungen untersucht. Eine stärkere Berücksichtigung linolensäurefreier Pflanzenlecithine, z. B. Sonnenblumen- oder Baumwoll-Lecithin, wird befürwortet.Vegetable Lecithins - Valuable Auxiliary and Active Substances?Up to now, only the soya bean lecithine has reached commercial importance among the many vegetable lecithins occurring during the processing of oil seeds. It gets into commerce in many varieties and is used as additive in technical products, food and feed, pharmaceutical products and other products. To the general public it is known as a tonic or medicine, and as a geriatric medicine, even though not in an undisputed way. The scientific basis which underlie the hitherto fields of application, and the chances of succeeding of further developments are investigated in this report. A greater consideration of vegetable lecithins without linolenic acid, for example sunflower or cotton lecithine, is approved.
    Chemische Revue über die Fett- und Harz-Industrie 01/1989; 91(2):45 - 58. DOI:10.1002/lipi.19890910202
  • [Show abstract] [Hide abstract]
    ABSTRACT: Characteristic features of alcoholic liver injury include fibrosis and striking membrane alterations, with associated phospholipid changes. To offset some of these abnormalities, a 10-yr study was conducted in baboons: 12 animals (eight females, four males) were fed a liquid diet supplemented with polyunsaturated lecithin (4.1 mg/kcal) for up to 8 yr, with either ethanol (50% of total energy) or isocaloric carbohydrate. They were compared with another group of 18 baboons fed an equivalent amount of the same diet (with or without ethanol), but devoid of lecithin. In the two groups, comparable increases in lipids developed in the ethanol-fed animals, but striking differences in the degree of fibrosis were seen. Whereas at least septal fibrosis (with cirrhosis in two) and transformation of their lipocytes into transitional cells developed in seven of the nine baboons fed the regular diet with ethanol, septal fibrosis did not develop in any animals fed lecithin (p less than 0.005). They did not progress beyond the stage of perivenular fibrosis (sometimes associated with pericellular and perisinusoidal fibrosis) and had a significantly lesser activation of lipocytes to transitional cells. Furthermore, when three of these animals were taken off lecithin, but continued on the same amount of the ethanol-containing diet, they rapidly (within 18 to 21 mo) progressed to cirrhosis, accompanied by an increased transformation of their lipocytes to transitional cells. These results indicate that some component of lecithin exerts a protective action against the fibrogenic effects of ethanol. Because we had previously found that choline, in amounts present in lecithin, has no comparable action, the polyunsaturated phospholipids themselves might be responsible for the protective effect.
    Hepatology 12/1990; 12(6):1390-8. DOI:10.1002/hep.1840120621 · 11.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Much progress has been made in the understanding of the pathogenesis of alcoholic liver disease, resulting in improvement of prevention and therapy, with promising prospects for even more effective treatments. The most successful approaches that one can expect to evolve are those that deal with the fundamental cellular disturbances resulting from excessive alcohol consumption. Two pathologic concepts are emerging as particularly useful therapeutically. Whereas it continues to be important to replenish nutritional deficiencies, when present, it is crucial to recognize that because of the alcohol-induced disease process, some of the nutritional requirements change. This is exemplified by methionine, which normally is one of the essential amino acids for humans, but needs to be activated to S-adenosylmethionine (SAMe), a process impaired by the disease. Thus, SAMe rather than methionine is the compound that must be supplemented in the presence of significant liver disease. Indeed, SAMe was found to attenuate mitochondrial lesions in baboons, replenish glutathione, and significantly reduce mortality in patients with Child A or B cirrhosis. Similarly, polyenylphosphatidylcholine (PPC) corrects the ethanol-induced hepatic phospholipid depletion as well as the decreased phosphatidylethanolamine methyltransferase activity and opposes oxidative stress. It also deactivates hepatic stellate cells, whereas its dilinoleoyl species (DLPC) increases collagenase activity, resulting in prevention of ethanol-induced septal fibrosis and cirrhosis in the baboon. Clinical trials with PPC are ongoing in patients with alcoholic liver disease. Furthermore, enzymes useful for detoxification, such as CYP2E1, when excessively induced, become harmful and should be downregulated. PPC is one of the substances with anti-CYP2E1 properties that is now emerging. Another important aspect is the association of alcoholic liver disease with hepatitis C: a quarter of all patients with alcoholic liver disease also have markers of HCV infection, with an even higher incidence in some urban areas but, at present, no specific therapy is available since interferon is contraindicated in that population. However, in addition to antiviral medications, agents that oppose oxidative stress and fibrosis should also be tested for hepatitis C treatment since these two processes contribute much to the pathology and mortality associated with the virus. In addition to antioxidants (such as PPC, silymarin, alpha-tocopherol and selenium), anti-inflammatory medications (corticosteroids, colchicine, anticytokines) are also being tested as antifibrotics. Transplantation is now accepted treatment in alcoholics who have brought their alcoholism under control and who benefit from adequate social support but organ availability is still the major limiting factor and should be expanded more aggressively. Finally, abstinence from excessive drinking is always indicated; it is difficult to achieve but agents that oppose alcohol craving are becoming available and they should be used more extensively.
    Journal of Hepatology 02/2000; 32(1 Suppl):113-28. DOI:10.1016/S0168-8278(00)80420-1 · 11.34 Impact Factor
Show more